13 March 2024
HeiQ PLC
("HeiQ"
or "the Company")
Result of General Meeting,
Issue of Equity & Total Voting Rights
The Company announces that all
Resolutions were duly passed by Shareholders at the General Meeting
held today in connection with the recently announced
Fundraising.
The results of the voting were as
follows:
|
Resolution
|
In favour
|
Against
|
Withheld
|
|
1. To sub-divide the ordinary
shares
|
43,627,201
|
3,213,056
|
56,011
|
|
2. to amend the company's
articles
|
43,627,
704
|
3,212,556
|
56,011
|
|
3. to authorise the directors
to allot ordinary shares
|
43,634,062
|
3,206,201
|
56,011
|
|
4. to authorise the directors
to disaaply pre-emption rights
|
43,627,710
|
3,212,556
|
56,011
|
Copies of the resolutions required
to be made available for inspection in accordance with LR 9.6.2
have been submitted today to the Financial Conduct Authority and
will shortly be available for inspection on the National Storage
Mechanism website at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
Accordingly, the Company announces
the issuance of 28,000,000 New Ordinary Shares and
applications have been made for the
28,000,000 New Ordinary Shares to be admitted to the standard
segment of the Official List and admitted to trading on the London
Stock Exchange ("Admission"), comprising (i) 7,866,709
Placing Shares; (ii) 862,069 Retail Shares and (iii) 19,271,222
Convertible Loan Note Shares. Admission is expected to occur
tomorrow, 14 March 2024.
Following the issue and allotment of
the New Ordinary Shares the Company has 168,537,907 Ordinary Shares
in issue. The Company holds no Ordinary Shares in treasury, and
therefore the total number of voting rights in the Company is
168,537,907. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
Furthermore, the Capital
Reorganisation which comprises a subdivision of each Existing
Ordinary Share of 30p into one New Ordinary Share of 5 pence and
one Deferred Share of 25 pence, will become effective tomorrow.
This is a technical change only and does not affect the rights of
any holder of Existing Ordinary Shares.
Unless otherwise defined,
capitalised terms shall have the same meaning as those set out in
its announcement regarding the Fundraising dated 15 February
2024.
For further information, please
contact:
|
HeiQ Plc
Carlo Centonze (CEO)
|
+41 56 250 68 50
|
|
Cavendish Capital Markets Limited (Broker)
Stephen Keys / Callum
Davidson
|
+44 (0) 207 397 8900
|
|
SEC
Newgate (Media Enquiries)
Elisabeth Cowell / Molly Gretton /
Tom Carnegie
|
+44 (0) 20 3757 6882
HeiQ@secnewgate.co.uk
|
Further information on the Company
can be found on its website at: https://www.heiq.com/investor-relations/
This announcement should be read in
its entirety. In particular, the information in the "Important
Notices" section of the announcement should be read and
understood.
About HeiQ
HeiQ is a Swiss-based international
company that innovates pioneering and differentiating materials in
partnership with established global brands. We bridge the academic
and commercial worlds to conceive performance-enhancing materials
and technologies, working with aligned brands to research,
manufacture and bring products to market, aiming for lab to
consumer in months. Our goal is to improve the lives of billions by
innovating the materials that go into everyday products, making
them more hygienic, comfortable, protective, and
sustainable.
Our strong IP portfolio positions us
as an innovation leader for niche, premium and high-margin products
in the textile chemicals, man-made fibers, paints and coatings,
antimicrobial plastics, probiotics and household cleaner markets.
We have also expanded into healthcare facilities, probiotic
cleaning, and hygiene coatings markets to help make hospitals and
healthcare environments more hygienic.
We have developed over 200
technologies in partnership with 300 major brands. With a
substantial research and development pipeline, including key
technology development projects HeiQ AeoniQ, HeiQ ECOS, HeiQ
GrapheneX, and HeiQ Synbio, HeiQ aims to deliver shareholder value
through sales growth and entry into new lucrative markets through
disruptive innovation and M&A.
We have built a strong reputation
for ESG & sustainable innovation, having won multiple awards
including the Swiss Technology Award twice and the Swiss
Environmental Award. Under experienced leadership, we are committed
to driving our profit in close connection with people and the
planet. For more information, please visit www.heiq.com.